Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SEER
#3963
Seer, Inc. Class A Common Stock
1.9
4
USD
+1.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.04%
Monthly Change
+7.18%
6 month change
-13.00%
Year Change
-7.18%
Previous Close
1.9
2
Open
1.9
4
Bid
Ask
Low
1.9
4
High
1.9
4
Volume
4
Markets
US Stock Market
Healthcare
SEER
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
2025
Total assets
539.14 M
487.93 M
436.27 M
366.6 M
296.08 M
Total liabilities
36.22 M
40.94 M
39.37 M
39.03 M
36.78 M
Total equity
502.92 M
446.99 M
396.9 M
327.57 M
259.31 M
Total liabilities & shareholders' equities
539.14 M
487.93 M
436.27 M
366.6 M
296.08 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
News
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Seer earnings beat by $0.02, revenue fell short of estimates
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way
Seer earnings missed by $0.01, revenue topped estimates
Seer Q3 2025 slides: modest revenue growth amid strategic repositioning
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Seer to showcase proteomics platform at ASHG 2025 annual meeting